Petros Pharmaceuticals
PTPI41
$0.06arrow_drop_down49.11%-$0.06
Penny Stock
PTPI41
$0.06
arrow_drop_down49.11%Performance History
| Key Stats | |
|---|---|
| Open | $0.06 |
| Prev. Close | $0.12 |
| EPS | -3.80 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $342.52K |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.03 | 0.21 |
| 52 Week Range | 0.03 | 2.27 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | -3.80 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Petros Pharmaceuticals (PTPI)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Headquarters
- New York
- Employees
- 24
- Exchange
- NASDAQ
Keep an eye on Petros Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Petros Pharmaceuticals (PTPI) stock price performance year to date (YTD)?
As of the latest data, Petros Pharmaceuticals (PTPI) has a year-to-date price change of -99.33%. Over the past month, the stock has experienced a price change of -95.06%. Over the last three months, the change has been -97.74%. Over the past six months, the figure is -99.02%.
help
What is Petros Pharmaceuticals's (PTPI) price per share?
The current price per share for Petros Pharmaceuticals (PTPI) is $0.07. The stock has seen a price change of -$0.06 recently, indicating a -49.11% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Petros Pharmaceuticals (PTPI)?
For Petros Pharmaceuticals (PTPI), the 52-week high is $2.27, which is 3.32K% from the current price. The 52-week low is $0.04, the current price is 83.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Petros Pharmaceuticals (PTPI) a growth stock?
Petros Pharmaceuticals (PTPI) has shown an average price growth of -1.65% over the past three years. It has received a score of 1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Petros Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
Is Petros Pharmaceuticals (PTPI) a profitable company?
Petros Pharmaceuticals (PTPI) has a net income of -$8.16M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 71.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -148.43% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $4.19M. Operating income is noted at -$13.62M. Furthermore, the EBITDA is -$10.61M.
help
What is the market capitalization of Petros Pharmaceuticals (PTPI)?
Petros Pharmaceuticals (PTPI) has a market capitalization of $342.52K. The average daily trading volume is 0.13, indicating the stock's liquidity and investor engagement.